2022 annual financial data
NervGen Pharma 2022 Financial results
Direct answer
Revenue was 0 CAD.
Operating income was -22,822,534 CAD and net income was -20,540,037 CAD.
Operating cash flow was -17,627,757 CAD.
Get free NervGen Pharma email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 CAD
- Operating income
- -22,822,534 CAD
- Net income
- -20,540,037 CAD
- Operating cash flow
- -17,627,757 CAD
Explore related company data
View all 2022 financial metricsView RevenueView Operating incomeView Net incomeView Operating cash flowView Revenue growthView Operating income growthView Net income growthView Operating cash flow growthView Operating marginView Net marginView Operating cash flow marginView all NervGen Pharma financial years